Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 8/20 | 0.51 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | TACR1 | P25103 | 10/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8458434 | 0.86 | DPP4 (0.52) | DPP4TACR1CNR1 | |
| SCHEMBL8947928 | 0.86 | DPP4 (0.52) | DPP4KCNA5KCNH2TACR1CNR1 | |
| SCHEMBL8948009 | 0.84 | DPP4 (0.52) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL8948056 | 0.82 | DPP4 (0.51) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL8947932 | 0.79 | DPP4 (0.54) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL8947976 | 0.77 | DPP4 (0.52) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL9233934 | 0.77 | DPP4 (0.49) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL8948059 | 0.77 | DPP4 (0.49) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL8947969 | 0.76 | DPP4 (0.52) | DPP4KCNA5KCNH2TACR1 | |
| SCHEMBL8947981 | 0.76 | DPP4 (0.49) | DPP4KCNA5KCNH2TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5527811-A | CALCIUM- AND SUBSTANCE P RECEPTOR-ANTAGONIST ACTIVITY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-06-18 | — | — | US | disclosed |
| EP-0634402-A1 | Isochinolinone derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1995-01-18 | — | — | EP | disclosed |